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We previously reported that dietary acrylamide, at doses (10 and
50 mg/kg diet) known to cause rodent tumors, lowered serum
total high density lipoprotein and total testosterone, increased
serum lipase, and lowered lymphocytes levels together with
other hematological parameters in male F344 rats exposed for 10
weeks (doi: 10.1016/j.etap.2014.11.009 [1]). Here we present data
related to the role of food-borne acrylamide exposure (at 0, 5, 10
and 50 mg/kg diet) in the presence of low (7% wt/wt) or high
(23.9% wt/wt) dietary fat on serum and urinary markers of oxi-
dative stress and inﬂammation in F344 rats. Brieﬂy, urine and
serum samples were collected from the experimental animals a
day prior to or at the time of necropsy, respectively and pro-
cessed for enzyme-linked immunosorbent assay estimations of
biochemical markers. Urine samples were analyzed for 8-
hydroxydeoxyguanosine and isoprostane, and serum samples
for total antioxidant capacity, paraoxonase 1 activity, c-reactive
protein, homocysteine, oxidized low-density lipoprotein, inter-
cellular adhesion molecule-1, thromboxin 2, and Nε-(carbox-
ymethyl)lysine.
Crown Copyright & 2016 Published by Elsevier Inc. This is an
open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Elsevier Inc. This is an open access article under the CC BY license
Sir Frederick Banting Driveway, Ottawa, K1A 0K9, Ontario, Canada.
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Dubject area Toxicology
ore speciﬁc sub-
ject areaFood toxicology, systemic oxidative stress and inﬂammationype of data Figures, Table.
ow data was
acquiredAll data was acquired using the POLARstar Omega multi-mode microplate
reader(BMG LABTECH Inc., Cary, NC, USA)ata format Analyzed data
xperimental
factorsUrine and serum from rats exposed to dietary acrylamide were processed and
individual enzyme-linked immunosorbent assays (ELISAs) were performed to
investigate markers of oxidative stress and inﬂammation.xperimental
featuresMale F344 rats were fed an AIN93 G basal diet containing low fat (7% wt/wt)
or high fat (23.9% wt/wt) and 0, 5, 10, or 50 mg/kg diet acrylamide for 8 weeks.
Rats were placed in metabolic cages 24 h before necropsy for urine sample
collection. Blood samples were collected from abdominal aorta at necropsyata source
locationOttawa, Ontario, Canadaata accessibility Data is with this articleDValue of the data We explored the role of chronic exposure to food-borne acrylamide in modulating markers of
systemic oxidative stress and inﬂammation in rats under low and high fat diet conditions.
 This systemic biochemical data will support previous ﬁndings of acrylamide exposure at doses
known to cause rodent tumors.
 Our data will be beneﬁcial in updating the existing toxicity information available on food-borne
acrylamide for regulatory purposes.1. Data
The present dataset includes results of biochemical estimations that determined markers of sys-
temic oxidative stress and inﬂammation in urine and serum samples of F344 rats exposed to dietary
acrylamide (Figs. 1–10; Table 2). These results of individual biochemical markers are to be interpreted
with the clinical biochemistry, hematology and pathology data previously reported [1].2. Experimental design, materials and methods
2.1. Animals, care and diets
The experimental protocol involving animals was reviewed and approved by the Health Canada
Ottawa Animal Care Committee prior to the commencement of the study. Animals were cared for
according to the guidelines of the Canadian Council on Animal Care. Six-week-old male F344 rats
were procured from Charles River Laboratories Canada (St. Constant, Quebec, Canada) and were pair-
housed in laboratory conditions with a 12 h light/12 h dark cycle. Temperature and relative humidity
were controlled at 22 °C and 55%, respectively. All animals were acclimatized to the above conditions
for 1 week until initiation of the experiment. The rats had free access to either lab chow (during the
acclimatization phase) or experimental diets and drinking water ad libitum. The experimental diets
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Fig. 2. Urinary isoprostane levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/kg
diet, n¼8/group. The histograms represent mean values7SEM. “*” indicates signiﬁcant difference at po0.05.
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Fig. 1. Urinary 8-hydroxydeoxyguanosine (8OHdG) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acry-
lamide at 0, 5, 10 or 50 mg/kg diet, n¼8/group. The histograms represent mean values7SEM. “aaa”, “bbb”, and “ccc” are
signiﬁcantly different from “A”, “B”, and “C” respectively at po0.001. ”d” is signiﬁcantly different from “D” at po0.05. “*”
indicates signiﬁcant difference at po0.05.
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Fig. 3. Serum total antioxidant capacity (TAC) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at
0, 5, 10 or 50 mg/kg diet, n¼8/group. The histograms represent mean values7SEM.
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Fig. 5. Serum c-reactive protein (CRP) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10
or 50 mg/kg diet, n¼8/group. The histograms represent mean values7SEM. “a” and “b” are signiﬁcantly different from “A” and
“B” at po0.05, respectively. “aa” is signiﬁcantly different from “A” at po0.01. “*” and “**” indicate signiﬁcant difference at
po0.05 and po0.01, respectively.
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Fig. 4. Serum paraoxonase 1 (PON1) activity in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10
or 50 mg/kg diet, n¼8/group. The histograms represent mean values7SEM. “a” is signiﬁcantly different from “A” at po0.05.
“*” indicates signiﬁcant difference at po0.05.
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Fig. 6. Serum homocysteine level in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or 50 mg/
kg diet, n¼8/group. The histograms represent mean values7SEM. “aaa” is signiﬁcantly different from “A” at po0.001.
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Fig. 7. Serum oxidized low-density lipoprotein (Ox-LDL) levels in rats fed low fat (LF) or high fat (HF) diet and treated with
acrylamide at 0, 5, 10 or 50 mg/kg diet), n¼8/group. The histograms represent mean values7SEM.
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Fig. 8. Serum intercellular adhesion molecule-1 (ICAM-1) levels in rats fed low fat (LF) or high fat (HF) diet and treated with
acrylamide at 0, 5, 10 or 50 mg/kg diet, n¼8/group. The histograms represent mean values7SEM. “aaa” is signiﬁcantly dif-
ferent from “A” at po0.001. “*” and “**” indicate signiﬁcant difference at po0.05 and po0.01, respectively.
X. Jin et al. / Data in Brief 7 (2016) 460–467464were isocaloric and based on the AIN-93G rodent semisynthetic diet formula [2], but containing corn
oil instead of soy oil as published earlier [3]. Fat level in the diet was maintained at either low (7%, wt/
wt) or high (23.9%, wt/wt). Diets were obtained from Research Diets, Inc. (New Brunswick, NJ, USA) in
the form of powder. Acrylamide was mixed with the diets at the required dose using a Hobart mixer,
and then made into pellets using a pelleting press. Diets were never exposed to high temperature
during processing and were stored in the dark at 4 °C until use. Rats were monitored every day and
their body weights and food consumption were recorded twice a week; diets were replenished
weekly.
2.2. Experimental design
After the acclimatization phase, animals (n¼64) were randomized (24 factorial) into eight
dietary groups (n¼8 rats/group) to receive low or high fat diets without or with acrylamide (0, 5, 10
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Fig. 9. Serum thromboxin 2 (TBX2) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide at 0, 5, 10 or
50 mg/kg diet, n¼8/group. The histograms represent mean values7SEM.
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Fig. 10. Serum Nε-(carboxymethyl)lysine (CML) levels in rats fed low fat (LF) or high fat (HF) diet and treated with acrylamide
at 0, 5, 10 or 50 mg/kg diet. The histograms represent mean values7SEM, n¼8/group.
X. Jin et al. / Data in Brief 7 (2016) 460–467 465or 50 mg/kg diet). All animals remained on the experimental diets for a total of 10 weeks. A day
before euthanasia, animals (not fasted) were placed in metabolic cages overnight, after which urine
was collected (on ice) and urine volume was recorded for assay dilutions and calculations. Following
urine collection, all rats were killed by exsanguination under isoﬂurane anesthesia, and blood was
drawn from the abdominal aorta into BD Vacutainer SST™ blood collection tubes (Becton-Dickinson,
Franklin Lakes, NJ, USA). Urine was centrifuged at 4000 g and serum was separated by centrifuga-
tion at 700 g, and in both cases the supernatant was collected, aliquots prepared, and stored at
80 °C until analysis.2.3. Enzyme-linked immunosorbent assay (ELISA)
Urine samples were analyzed for 8-hydroxydeoxyguanosine and isoprostane, and serum samples
for total antioxidant capacity, paraoxonase 1 activity, c-reactive protein, homocysteine, oxidized low-
density lipoproetein, intercellular adhesion molecule-1, thromboxin 2, and Nε-(carboxymethyl)lysine
Table 2
Spearman correlation (coefﬁcient) between acrylamide dose and oxidative stress and inﬂammatory markers.
Marker 8OHdG Isoprostane TAC PON1 CRP HCy Ox-LDL ICAM-1 TBX2 CML
Low fat diet
Acrylamide 0.681*** NS NS 0.418* NS 0.563** NS NS NS NS
8OHdG NS 0.461* NS NS NS NS NS NS NS NS
Isoprostane NS NS NS 0.519* NS NS NS NS NS NS
TAC NS NS NS NS NS NS NS NS NS NS
PON1 NS NS 0.392* NS NS NS NS 0.399* NS NS
CRP NS NS NS NS NS 0.430* NS NS NS NS
Hcy NS NS NS NS NS NS NS 0.443* NS NS
Ox-LDL NS NS NS NS NS NS NS 0.500** NS NS
ICAM-1 NS NS NS NS NS NS NS NS NS NS
TBX2 NS NS NS NS NS NS NS NS NS NS
High fat diet
Acrylamide 0.636*** NS NS 0.487** 0.711*** NS NS 0.615*** NS NS
8OHdG NS NS NS 0.363* 0.769 0.536** NS 0.646*** NS NS
Isoprostane NS NS NS NS NS NS 0.509* NS NS NS
TAC NS NS NS NS NS NS NS NS NS NS
PON1 NS NS NS NS 0.408* NS NS 0.409* NS NS
CRP NS NS NS NS NS 0.451** NS 0.623*** NS NS
Hcy NS NS NS NS NS NS NS 0.380* NS NS
Ox-LDL NS NS 0.383* NS NS NS NS NS NS NS
ICAM-1 NS NS NS NS NS NS NS NS NS NS
TBX2 NS NS NS NS NS NS NS NS NS NS
“*”,“**” and "***" indicate signiﬁcant difference at po0.05, po0.01 and po0.001, respectively.
Table 1
Manufacturer details of commercial kits used and test sample dilution factor for individual assays.
Assay name Catalog
number
Manufacturer (City, Country) Dilution of urine/
blood
8-hydroxydeoxyguanosine KOG-200 S/E JaICA Shizuoka, Japan 1urine
Isoprostane EA85 Oxford Biomedical Research, Rochester Hills, MI,
USA
10urine
Total antioxidant capacity NX 2332 Randox Laboratiories, Antrim, UK 1 serum
Paraoxonase 1 E33702 Thermo Fisher Scientiﬁc Inc. Waltham, MA, USA 170 serum
c-Reactive protein (CRP) 41-CRPRT-E01 Alpco Salem, NH, USA 12,000 serum
Homocysteine (HCy) 194-5361 Bio-Rad Laboratories, Inc. Hercules, CA, USA 1 serum
Oxidized LDL 10-1158-01 Mercodia AB Uppsala, Sweden 21 serum
Intercellular adhesion mole-
cule-1
RIC100 R&D Systems Minneapolis, MN, USA 51 serum
Thromboxin 2 900-002 Assay Designs, Inc., Ann Arbor, MI, USA 400 serum
Nε-(carboxymethyl)lysine CY-8066 CycLex Co., Ltd. Nagano-shi. Japan 6 serum
X. Jin et al. / Data in Brief 7 (2016) 460–467466carried out by the ELISA method using commercial kits according to the manufacturer's instructions.
Details of the kits and test sample dilutions of individual assays are given in Table 1.2.4. Statistical analysis
Data was analyzed performed using SigmaPlot 11.0. Statistical comparisons were performed
using ANOVA with Tukey's post hoc test. For all tests, po0.05 was considered as statistically
signiﬁcant.
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